FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer

Manojit Mosur Swamynathan(Cold Spring Harbor Laboratory), Lloyd C. Trotman(Cold Spring Harbor Laboratory)

Cancers

December 21, 2023

10.3390/cancers16010060

Cited by 10

Related Papers

Pten Dose Dictates Cancer Progression in the Prostate

|PLoS Biology|2003|667

Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function

|Science|2024|44